Dr. Gil Van Bokkelen is the Chairman and CEO of Athersys, Inc. (NASDAQ: ATHX), a biopharmaceutical company based in Cleveland, Ohio that was established in 1995. He has served as Chairman of the Board of Directors at Athersys since August, 2000, and as CEO since the com…more ›

Gil van Bokkelen

Chairman & CEO

Athersys

Gary Rabin has a 23-year career in finance and operations that primarily encompasses investing in, managing and capital-raising for small-cap and emerging growth companies. From 2007 to 2010, he was the Managing Partner of GR Advisors, LLC, investment manager for two lo…more ›

Gary Rabin

Chief Executive Officer

Advanced Cell Technology

Michael Hunt was appointed Chief Executive Officer of ReNeuron in July 2005. Prior to ReNeuron, he spent six years at Biocompatibles International plc (sold to BTG plc) where he held a number of senior financial and general management positions. His early industrial car…more ›

Michael Hunt

CEO

ReNeuron Group plc

Richard Garr, JD, has been a director and our Chief Executive Officer since 1996. Mr. Garr was previously an attorney with Beli, Weil & Jacobs, the B&G Companies, and Circle Management Companies. Mr. Garr is a graduate of Drew University (1976) and the Columbus …more ›

Richard Garr

CEO

Neuralstem

Timothy M. Mayleben, Mr. Mayleben joined Aastrom as a member of the Companys Board of Directors in June 2005, and currently serves as Chief Executive Officer, President, Chief Financial Officer and Director. Mr. Mayleben was formerly an advisor to life science and hea…more ›

Timothy Mayleben

CEO, President & Director

Aastrom Biosciences

The region's largest stem cells and regenerative medicine industry conference

The stem cell and regenerative medicine industry is burgeoning to a critical mass and pioneering to
transform the future of healthcare.

Engage in a global forum with senior level decision makers at Europe’s largest executive level stem cell conference and make sure you learn from the recent successes and failures experienced during cell therapy development.

Download the World Stem Cells & Regenerative Medicine Congress 2012 brochure ›

Come to World Stem Cells & Regenerative Medicine Congress and learn how to:

Overcome regulatory hurdles
Identify successful stem cell therapy
Obtain reimbursement
Understand Stem Cells in a new age of Drug Discovery
Explore commercial potential in academic research
Use stem cell technology for drug target discovery and toxicity testing
Secure investment for stem cell product development

Limited opportunities to speak at the conference exist for leading solution providers

New co-location to 2012:

In 2012, World Stem Cells and Regenerative Medicine Congress will be co-located with the World Gene Therapy Congress for the first time. With the obvious synergies between Cell and Gene Therapy, this new brand addition will look to expand upon the number of pharma, biotech and academic organisations and representatives attending from these two burgeoning industries.

This new addition can only help to create additional value to existing and new clients of the World Stem Cells and Regenerative Medicine brand.

Visit the website ›

become a sponsor ›